Webinar Date/Time: Thursday, March 21, 2024 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Real-world data (RWD) and real-world evidence (RWE) are playing increasingly important roles in healthcare and are making it possible for decision makers to gain insights and incorporate more data quickly into research decisions. Optimization of this data will enable researchers to design and conduct clinical trials more efficiently, both from a cost and timeline perspective. This webinar focuses on the significance of leveraging data management technology to increase collaboration amongst stakeholders and maximize the value derived from the data provided newer platforms.
Register Free: https://www.pharmexec.com/pe/rethink-reignite-reimagine
Event Overview:
Real-world data (RWD) and real-world evidence (RWE) are playing increasingly important roles in healthcare and are making it possible for decision makers to gain insights and incorporate more data quickly into research decisions. Optimization of this data will enable researchers to design and conduct clinical trials more efficiently, both from a cost and timeline perspective.
However, accessing and analyzing large amounts of data can be unwieldy and resource intensive. How do we ensure sponsors, sites, regulatory authorities, and study teams can efficiently and easily manage this wealth of new data to deliver actionable insights? And how can we streamline complex data sets into a single and actionable source of truth?
This webinar focuses on the significance of leveraging data management technology to increase collaboration amongst stakeholders and maximize the value derived from the data provided newer platforms.
Key Learning Objectives
Who Should Attend
This webinar is applicable to:
Full Agenda
Thursday, March 21st:
11:00 am EDT Unlocking Potential and Navigating Limitations of Using Real-World Evidence in Safety
Martina Furegato, Associate Principal; Oracle Life Sciences
Robert Weber, Product Management Director; Oracle Life Sciences
Elise Berliner, Global Senior Principal of Real-World Evidence Strategy; Oracle Life Sciences
12:00 pm EDT Taming the Data Tsunami From Decentralized Clinical Trials and Real-World Data
David Blackman, Executive Director Digital Trials Strategy; Oracle Life Sciences
1:00 pm EDT Creating the Future in Clinical Research with CROs Using Real-World Data
Speakers:
Martina Furegato
Associate Principal
Oracle Life Sciences
Robert Weber
Product Management Director
Oracle Life Sciences
Elise Berliner
Global Senior Principal of Real-World Evidence Strategy
Oracle Life Sciences
David Blackman
Executive Director Digital Trials Strategy
Oracle Life Sciences
Register Free: https://www.pharmexec.com/pe/rethink-reignite-reimagine
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.